Form 4: Envista Holdings Director R. Scott Huennekens Receives Annual Equity Grant

Envista Holdings Corp. Director R. Scott Huennekens was granted 14,370 Restricted Stock Units as part of his annual compensation, increasing his total beneficial ownership to 69,520 shares.

Summary

• R. Scott Huennekens, a Director of Envista Holdings Corp. (NVST), acquired 14,370 shares of common stock on June 10, 2025.
• This acquisition was an annual equity grant of Restricted Stock Units (RSUs) for his service as a director.
• The RSUs were granted at a price of $0, indicating they are compensation rather than a purchase.
• These RSUs will vest on the first anniversary of the grant date, which is June 10, 2026.
• Following this transaction, Mr. Huennekens' direct beneficial ownership of Envista Holdings common stock increased to 69,520 shares.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it represents a routine equity grant to a director, aligning their interests with shareholders. It's not highly impactful but indicates standard corporate governance practices.

Positives

• The grant of Restricted Stock Units to a director aligns management and director interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a routine annual equity grant, indicating a stable compensation structure for directors.

Negatives

• The issuance of new shares for RSU grants can lead to minor dilution for existing shareholders, although this is a common practice for equity compensation.

Risks

• The value of the granted RSUs, and thus the director's compensation, is subject to the future performance of Envista Holdings Corp.'s stock price until vesting.

Future Outlook

The 14,370 Restricted Stock Units granted to Director R. Scott Huennekens are scheduled to vest on June 10, 2026, which is the first anniversary of the grant date, at which point they will convert into shares of common stock on a one-to-one basis.

Management Comments

• Consists of an annual equity grant of Restricted Stock Units ('RSUs') for the Reporting Person's service as a director of the Issuer.

Industry Context

This Form 4 filing details a routine equity compensation grant to a director, a common practice across publicly traded companies to align the interests of board members with long-term shareholder value. Such grants are standard components of director remuneration in the broader corporate governance landscape.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as part of director compensation is a widely adopted practice among U.S. public companies, particularly within the healthcare and medical device sectors where Envista Holdings operates.
• Companies like Dentsply Sirona Inc. (XRAY) or Align Technology, Inc. (ALGN), while not directly comparable in terms of specific grant amounts without their respective filings, typically utilize similar equity-based compensation structures for their non-executive directors to foster long-term alignment and retention.
• The vesting schedule of one year is also a common standard for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor potential for dilution from the issuance of new shares upon RSU vesting, but also benefits from increased alignment of director interests with long-term stock performance.
• Director (R. Scott Huennekens): Receives equity compensation, increasing his stake in the company and tying his personal wealth to the company's stock performance.

Next Steps

• The granted Restricted Stock Units (RSUs) are expected to vest on June 10, 2026.

Key Dates

Keywords

Envista Holdings, NVST, Form 4, SEC Filing, Insider Transaction, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Beneficial Ownership